<- Go Home
Galea Life Sciences, Inc.
Galea Life Sciences, Inc., a research-focused life science company, engages in the discovery, development, and delivery of specialized therapeutic nutritional supplements and functional food products that complement prescribed drug therapy regimens. The company focuses on developing a pipeline of products for chemotherapy, frailty, gastric bypass, and more. Its flagship product is Nutraplete, a specialized therapeutic dietary supplement drink specifically designed to help people living with HIV/AIDS. The company was founded in 1992 and is based in Orlando, Florida.
Market Cap
N/A
Volume
N/A
Cash and Equivalents
$3.1K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$55.1K
Profit Margin
76.24%
52 Week High
N/A
52 Week Low
N/A
Dividend
N/A
Price / Book Value
N/A
Price / Earnings
N/A
Price / Tangible Book Value
N/A
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$38.5K
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
$3.1K
Debt
$3.2M
Equity
-$5.2M
Revenue
$72.3K
Unlevered FCF
N/A
Sector
Personal Care Products
Category
N/A